Profile: Ardea Biosciences, Inc. is a biotechnology company that focuses on the development of small-molecule therapeutics for the treatment of gout, cancer, inflammatory diseases and human immunodeficiency virus. Our advanced clinical stage product candidates include RDEA594, URAT1 transporter inhibitor for the treatment of hyperuricemia & gout; RDEA119, a specific inhibitor of mitogen activated ERK kinase for the treatment of cancer & inflammatory diseases, and RDEA806, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV.